RTTNews | Dec 12, 2021 09:38AM EST

09:37 Sunday, December 12, 2021 (RTTNews) - ImmunoGen Presents Initial Findings From Phase 1b/2 Study Of IMGN632 With Vidaza And Venclexta In R/R AML At ASH

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved